A A A

IHA News

Science Paper published

A recent Science article published by a team of UCL researchers including the IHA's Dr Teresa Niccoli sheds light into toxicity mechanisms. View the article here: http://goo.gl/2sgNCb More...

Published: Aug 19, 2014 10:24:04 AM

Knudra Transgenics prize success for IHA

In a recent competition organised by the biotech company KNUDRA TRANSGENICS three members of the IHA were awarded prizes to make custom transgenic animals.

Second prize $3000 to Nuria Vergara to develop the project "Can human FOXO3a replace DAF-16 to promote longevity in C. elegans?" using CRSPR technology.

Third prize £1500 to Jennifer Tullet to investigate "How do translational errors affect longevity and health in C. elegans?"

Sixth prize $500 to Lamia Mestek to expand our knowledge in "Understanding the role of DAF-16 transcription factor in longevity"

The results of the competition can be checked in the following link: http://knudragrants.knudra.com/?page_id=39

Congratulations to all the winners!!!
More...

Published: Aug 19, 2014 10:10:57 AM

New Wellcome Trust video 'Until' features IHA scientists

The Wellcome Trust’s online publication, Mosaic, have released a new video ‘Until’, an exploration of ageing which asks the question, ‘how long would you like to live?’. The video includes interviews with leading ageing scientists (including the IHA's David Gems and Linda Partridge), transhumanists, elderly people and the young children and asks them when they think would be an appropriate time to die, if they had the choice. It also explores the possibilities and realities of extended lifespans in the future. The video can be found here: http://youtu.be/BsUZHyh4n-c More...

Published: Aug 6, 2014 11:44:15 AM

About us


The Institute of Healthy Ageing (Director: Prof Dame Linda Partridge, DBE, FRS, FRSE, FMedSci) is an interdisciplinary centre of excellence for research on the biology of ageing and ageing-related diseases. The biological process of ageing contributes to increased risk of a wide range of diseases, from neurodegenerative diseases (e.g. Alzheimer's and Parkinson's disease) and cancer to cardiovascular disease (causing heart attack and stroke) and age-related macular degeneration (causing blindness in the elderly).

Our primary purpose is to bring together researchers working on the basic biology of ageing (biogerontology) with those working to understand the causes of ageing-related disease. By merging the two, we aim to develop a new translational biogerontology using the ageing process as a point of intervention to protect against the diseases of old age. Our goal is to improve the health and quality of life for older people.

The work of the Institute of Healthy Ageing is pursuing these ends by:

  • Conducting world class research on the biology of ageing and ageing-related disease
  • Increasing capacity in research on the biology of ageing by training new researchers and nurturing the work of younger principal investigators
  • Teaching about the biology of ageing at undergraduate and postgraduate levels

The problem of ageing is not just an issue of biology, but also of social science, economics and the built environment. A secondary aim of the Institute is to nurture broader collaborations across UCL between researchers working on different aspects of ageing.

We aim, through our combined activities, to transform healthcare technology and the social conditions of the elderly to create a future society in which the lives of older people are healthy, meaningful and happy. 

Our facilities are shared with the associated Bähler Lab, headed by Professor Jürg Bähler.

Page last modified on 03 jul 13 14:38